Improving LC-MS/MS measurements of steroids with differential mobility spectrometry

[Display omitted] •Measurements of many steroids are routinely used for clinical diagnosis.•Specific steroid measurements are challenging due to similarities amongst steroids.•DMS improves the specificity of traditional LC-MS/MS techniques.•DMS improves the S/N and reduces interferences.•Validation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of mass spectrometry and advances in the clinical lab 2023-11, Vol.30, p.30-37
Hauptverfasser: Chai, Yubo, Grebe, Stefan K.G., Maus, Anthony
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Measurements of many steroids are routinely used for clinical diagnosis.•Specific steroid measurements are challenging due to similarities amongst steroids.•DMS improves the specificity of traditional LC-MS/MS techniques.•DMS improves the S/N and reduces interferences.•Validation of cortisol/cortisone in urine demonstrates the viability of DMS. Steroid measurements are important for diagnosis and monitoring of many conditions and treatment regiments; however, due to structural and chemical similarities amongst steroids, these analyses are challenging, even for highly specific techniques such as liquid chromatography-tandem mass spectrometry (LC-MS/MS). Differential mobility spectrometry (DMS) has the potential to improve these analyses by providing an orthogonal and complementary separation technique. Initially, the potential for DMS to improve signal-to-noise ratio (S/N) and reduce interference was tested by comparing chromatograms acquired with and without DMS when performing measurements of six different steroids. Subsequently, a full clinical validation of cortisol and cortisone in urine was performed with the LC-DMS-MS/MS method. DMS significantly reduced interferences observed in the chromatograms and boosted S/N by between 1.6 and 13.8 times. Additionally, DMS improved the agreement between quantifier/qualifier fragment ion results for cortisol and cortisone as indicated by the increase in R2 from approximately 0.81 to 0.98. All validation studies met acceptance criteria and we observed exceptional analytical performance in terms of precision, with % CVs less than 8%. DMS improved the specificity of the steroid measurements by reducing interferences and improving S/N. The validation studies prove that these benefits did not come at the expense of other aspects of analytical performance. This study indicates that DMS has the potential to benefit not just clinical measurements of challenging analytes, but many clinical LC-MS/MS analyses.
ISSN:2667-145X
2667-1468
2667-145X
DOI:10.1016/j.jmsacl.2023.10.001